When 1384 patients experienced the primary endpoint (of the planned 1600 events), the study was prematurely terminated based on an interim analysis that demonstrated low probability of clinical benefit from the use of omega-3 CA vs
Neurological symptoms (tingling, balance issues) take longer, typically three to six months, and in some cases longer if deficiency was long-standing before supplementation began
We attached the purified multi-FN3-domain proteins via a His-tag to supported lipid bilayers containing Ni-chelating lipids on a glass bead
Therapy is preceded by physical examination and stan- dard laboratory assessment, as discussed previously
Honda, Y., Kessoku, T., Sumida, Y., Kobayashi, T., Kato, T., Ogawa, Y., Tomeno, W., Imajo, K., Fujita, K., Yoneda, M., Kataoka, K., Taguri, M., Yamanaka, T., Seko, Y., Tanaka, S., Saito, S., Ono, M., Oeda, S., Eguchi, Y., Nakajima, A
Furigo IC, Teixeira PD, Quaresma PGF, Mansano NS, Frazao R, Donato J